Healthcare

Insulin Pumps Market

By Segment, By Region, And Segment Forecasts, 2014 – 2023

Vertical: HealthcareBase Year: 201611 Sections

Executive Summary

Insulin Pumps Market — Snapshot

  • Market Size (2014)

    2014

    $2.36B

  • Projected (2023)

    2023

    $4.88B

  • CAGR (2014–2023)

    8.4%

    8.4%
  • Key Players

    106+

This report covers Insulin Pumps Market with forecasts from 2014 to 2023. 106 key companies are profiled.

Key Insight

The Insulin Pumps Market market is projected to grow at a CAGR of 8.4% from 2014 to 2023.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, North America, Asia Pacific, Europe.
  • Market Segmentation: The market is analyzed across 2 segments: Traditional insulin pump, Disposable insulin pump. Forecasts are provided for each segment from 2014 to 2023.
  • Competitive Landscape: 106 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Insulin Pumps Market — Growth Trajectory

Continuous subcutaneous insulin or the insulin pump has picked up popularity and advancement as a physiologic programmable technique for insulin delivery which is adaptable and lifestyle friendly. Furthermore, the introduction of constant observing with glucose sensors gives exceptional access, and forecast of, a patient's blood glucose levels. Research and development are in progress to coordinate the two technologies, from "sensor-augmented" and "sensor-driven" pumps to a completely automated and independent sensing and delivery system. Despite the fact that endocrinologists and diabetes authorities will keep on maintaining expertise in this field, it becomes essential for physicians to have a learning of insulin pumps and sensors to guarantee ideal clinical care and decision-making for their patients.

Insulin Pumps Market — Growth Trajectory

Traditional insulin pump
Disposable insulin pump

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Type Type is broken down into: Traditional insulin pump, Disposable insulin pump.
  • End User End User is broken down into: Hospital & Clinics, Home Care, Laboratories.

Geographic Analysis

Regional market breakdown

  • Middle East and Africa Middle East and Africa market size reached $87.20M in 2014 and is projected to reach $103.70M by 2023, growing at a CAGR of 1.9%.
  • North America North America market size reached $1.05B in 2014 and is projected to reach $2.22B by 2023, growing at a CAGR of 8.6%.
  • Asia Pacific Asia Pacific market size reached $382.00M in 2014 and is projected to reach $811.70M by 2023, growing at a CAGR of 8.7%.
  • Europe Europe market size reached $834.60M in 2014 and is projected to reach $1.74B by 2023, growing at a CAGR of 8.5%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Insulin Pumps Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2016

  • Historical Period

    2014 – 2016

  • Forecast Period

    2016 – 2023

  • Primary Interviews

    150+

Research Process

Historical data (2014–2016) and forecast period (2016–2023)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Insulin Pumps Market — Competitive Analysis

Bargaining Power of Buyers

The bargaining power of buyers in the insulin pumps market is medium. The market has a reasonable number of buyers, which include physicians, independent and device stores, research laboratories and patients. The existence of buyers in the market is high due to an increasing aging population, the rise in the prevalence of diabetes and lifestyle associated diseases. In addition, buyers are price sensitive, which discreetly affects bargaining power in the market. The insulin pumps market is characterized by a moderate degree of brand identity. Thus, brand plays an important role in the market, as buyers are moderately inclined towards recognized insulin pump manufacturers. In addition, switching cost is moderate for buyers, as pumps are cost-effective and are easily available in the market.

Bargaining Power of Suppliers

Bargaining power of suppliers in insulin pumps market is low to medium. Numbers of suppliers in the market are moderate which leads to the average bargaining power of suppliers. Another factor affecting the bargaining power of suppliers is the reasonable supplier switching cost for buyers. In addition, the low availability of substitutes moderately increases the bargaining power of suppliers. On the other hand, low chances of forwarding integration decrease the bargaining power of suppliers in the global insulin pumps market.

The Threat of New Entrants

The threat of new entrants is medium for the insulin pumps market. Any insulin pump manufacturing company trying to enter the market is required to follow strict regulatory standards to enter the industry. Moderate level of capital requirement is also a major barrier of entry for new players. The insulin pumps market is also characterized by a moderate degree of brand loyalty globally.

Rivalry

The degree of competition in the global insulin pump market is medium to high. The moderate grade of product differentiation among existing players, as insulin pumps are moderately expensive compared to various devices. Thus, this would increase the intensity of rivalry in the market. In addition, brand loyalty moderately affects the market, as buyers are moderately inclined towards established device manufacturers in the global insulin pumps market.

Threat of Substitutes

The threat of substitutes in the global insulin pumps market is medium to high. Substitutes, such as traditional methods, Self-Monitoring of Blood Glucose (SMBG) pose a moderate threat to the insulin pumps market; primarily due to their low cost. Buyers’ propensity towards the substitute is moderate. Thus, the availability of insulin pumps in rural areas is low due to poor healthcare infrastructure and high cost. In addition, the moderate degree of switching cost further minimizes the threat of substitute in the global insulin pumps market.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Insulin Pumps Market.

Regional Market Size (USD Mn)

Market estimates by geography (2023)

USD Mn

InsightNorth America leads with $2.22B by 2023, while Asia Pacific is projected to grow fastest at a 8.7% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201420162023CAGRSHARE
Middle East and Africa$87.20M$99.90M$103.70M1.9%2%
North America$1.05B$1.59B$2.22B8.6%46%
Asia Pacific$382.00M$580.80M$811.70M8.7%17%
Europe$834.60M$1.26B$1.74B8.5%36%
Total$2.36B$3.53B$4.88B8.4%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2023)

Traditional insulin pump
Disposable insulin pump
0944188828323776

Segment Market Share

  • Traditional insulin pump70%
  • Disposable insulin pump30%

Total Market Size

$4.88B

Market by Segment (2023)

APPLICATIONREVENUE ($B)GROWTH RATEMARKET PENETRATION
Traditional insulin pump$3.43B8.4%
85%
Disposable insulin pump$1.45B8.4%
82%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Insulin Pumps Market — Key Findings

Analytical insights on Insulin Pumps Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Insulin Pumps Market market is projected to reach $4.88B by 2023, growing at 8.4% CAGR. The Traditional insulin pump segment holds the largest share.

Market Drivers

Diabetes is a chronic disease and its global prevalence is increasing. It is one of the foremost causes of death and generates an increased risk of developing a number of serious health problems such as cardiovascular diseases, kidney diseases, eye disorders, stroke, and others.

The fact-sheet of the World Health Organization in 2017 stated that the global prevalence of diabetes among adults (18 years or more) has risen from 4.7% in 1980 to 8.5% in 2014. Likewise, according to the International Diabetes Federation (IDF) in 2013, ~592 million people are expected to suffer from diabetes by 2035.

In the presence of such trends for increasing diabetic population, a majority of the cases are estimated to be reported for the adult population aging 60 years or more. Thus, with the increasing number of diabetic patients, the demand for insulin devices is expected to grow parallelly and provide suitable backgrounds for the market to grow.

Market Restraints

Continuous testing of the glucose level is needed to avoid risks associated with insulin delivery devices. For example, the glucose level in insulin pumps is checked continuously to find if the tubing or cannula is disconnected or blocked. It may lead to various disadvantages and risks associated with the device, such as ketoacidosis due to breakdown or absorption problem, and skin infection at the catheter site. The risk of hypoglycemia, the risk of diabetic ketoacidosis (DKA) from pump malfunction or absorption problems, cost issues as pumps are expensive, and the continuing cost of supplies etc. are some of the risks and disadvantages associated with insulin pumps and are restraining the growth of the global insulin pumps market.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2023)

Value (USD Mn)
Traditional insulin pump
Disposable insulin pump

Companies

Key companies profiled in Insulin Pumps Market

Profiles of 106 companies operating in the Insulin Pumps Market market, including revenue, employee count, and market positioning where available.

Showing 106 of 106 companies

Insulet Co

Insulet Corporation

Healthcare

Established in 2000 and headquartered in Billerica, MA United States, Insulet Corporation is one of the leading insulin device companies in the US which is dedicated to making the lives of diabetic patients easier through one of its major products, named Omnipod Insulin Management System. The company’s major motive is to expand the use of insulin pumps among patients who are dependent on insulin pumps.

Revenue$0.0B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
F. HOFFMAN

F. HOFFMANN-LA ROCHE LTD

Healthcare

Incorporated in 1896 and headquarters in Basel, Switzerland; F. Hoffmann-La Roche AG is the world's biggest biotech organization, with genuinely differentiated solutions in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is additionally the world pioneer in vitro diagnostics and tissue-based cancer diagnostics, and a leader in diabetes management. The consolidated qualities of pharmaceuticals and diagnostics under one rooftop have made Roche the pioneer in personalized healthcare. The products offered by the company helps in tapping in the world’s two third of all the diseases which are either not treated effectively or not treated at all. The company offers various products in the Pharmaceutical, Diagnostics and research industry. Geographically the company operates in North America, Europe, South America, Africa, Asia and Oceania. As of 2015 F. Hoffmann-La Roche AG had a head count of 91,700 + employees world wide Roche Strategy – a methodology that intends to fit the right treatment to every patient in the most ideal way that could be available dedicated on developing innovative diagnostic tests and medicines which will help their patients and the world.

Revenue$63.3B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
SANOFI

SANOFI

Healthcare

Sanofi is a UK-based global life sciences company which was incorporated in the year 2004. Sanofi is headquartered in Paris having the employee strength of more than 110,000 spread in more than 100 countries and have industrial sites in more than 40 countries. The company is committed to improve the access to healthcare and support the people to whom it serves throughout the continuum of care. Further, the company has its offerings into healthcare solutions, human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, and consumer healthcare. Sanofi CEPiA is a subsidiary business unit of Sanofi that produces articaine hydrochloride in API form. It is a market leader in producing articaine hydrochloride. The company manufactures articaine hydrochloride in its high capacity FDA approved workshop. Sanofi’s Ankleshwar production plant has an export sales of Rs. 54,900 lakhs that is around 27% of their total sales in India in 2015 . Their healthcare solutions are available in more than 170 countries across the world and now Sanofi is focussing on increasing its presence in emerging countries. Their industrial network, know-how and employees deliver a wide range of health solutions to millions of individuals with high quality and safety. Some of the top competitors of Sanofi are Pfizer Inc., Merck & Co., Inc. GlaxoSmithKline Plc., Septodont, Dentsply Sirona, and Pierrel S.p.A., among others.

Revenue$40.5B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
MEDTRONIC

MEDTRONIC PLC

Healthcare

Company Headquarters: Dublin, Ireland Founded: 1949 Workforce: ~91,000 Company Working: Medtronic plc (Medtronic) is a global healthcare solutions company that focuses on improving the lives of people through medical technologies, solutions, and services. The company with Covidien has accelerated and advanced its abilities to create meaningful innovations for hospitals, health systems, and healthcare providers. The company’s businesses majorly fall into four groups: the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group, and the Minimally Invasive Therapies Group (MITG). Medtronic operates from over 370 locations in almost 160 countries. The company has been at the forefront of the cardiac telemedicine industry with patented technologies such as ambulatory devices with unified analysis & reporting software and on-site diagnostic systems. The company is committed to advancing science in patient monitoring. The company is awarded more than 4,600 patents.

Revenue$28.8B
Employees91,000
Market CapN/A
Founded1948
Dublin, Ireland
B. BRAUN M

B. BRAUN MELSUNGEN AG

Healthcare

Established in 1839 and headquartered in Germany, B.Braun is a leading healthcare supplier. The company provides its products for hospitals, surgeries, private practices (medical care and doctors´ offices), and extracorporeal blood treatments. The company’s product segments include clinical nutrition, urinary care, infection prevention, insulin therapy, diabetes care, neurosurgery, extracorporeal blood treatment, IV drugs, orthopaedics, spine, and wound care, amongst others. B.Braun operates in four major divisions, namely, Hospital Care, Aesculap, Out Patient Market, and B. Braun Avitum. With these four divisions, the company has a wide range of products with about 5,000 products, out of which 95% of the products are manufactured by the company. Geographically the company operates in 64 countries in regions such as Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The company generated a revenue of about USD 6672 million in 2015 with a head count of more than 55,000 employees all around the globe.

Revenue$6.9B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
ABBOTT LAB

ABBOTT LABORATORIES

Food & Beverages

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Illinois, US Founded: 1888 Workforce: ~103,000 Company Working: Abbott Laboratories is engaged in the research, manufacture, and sale of branded generic pharmaceuticals, nutritional products, medical devices, and diagnostics. The company operates in the US, the Netherlands, Germany, Japan, Italy, France, Canada, the UK, and Spain. The four major segments of the company are nutritionals, diagnostics, established pharmaceutical products, and cardiovascular & neuromodulation, and others. The nutritional segment of the company includes a broad line of pediatric and adult nutritional products. The nutritionals segment also includes nutritional products used in enteral feeding in healthcare institutions.

Revenue$31.9B
Employees103,000
Market CapN/A
Founded1887
Illinois, US
Page 1 of 18
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Insulin Pumps Market

Starting from
$4,950